Multispectral Optoacoustic Tomography in Crohns disease - A First-in-human Diagnostic Clinical Trial

Conclusion: MSOT is the first non-invasive, isotope- and contrast-agent-free, bed-side imaging modality to predict endoscopic/histologic disease activity in patients with CD. This preliminary study suggests that MSOT-based assessment of haemoglobin levels in the intestinal wall may be able to assess remission and active disease in CD without the need for more invasive procedures. Research Support: German Research Foundation, Graduate School in Advanced Optical Technologies, Center for Clinical Research, and the Emerging Fields Initiative of the Friedrich-Alexander-Universität Erlangen-Nürnberg.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Gastrointestinal Nuclear Medicine Source Type: research